ClinicalTrials.govpublic full text
A Study Evaluating Venetoclax (ABT-199) in Multiple Myeloma Subjects Who Are Receiving Bortezomib and Dexamethasone as Standard Therapy
relapsed/refractory multiple myeloma, relapsed multiple myeloma, refractory multiple myeloma, multiple myeloma, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 805175
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.